Are European laboratories ready to detect COVID-19?
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
In January 2020, a survey among laboratories to assess the capacity and quality for SARS-CoV-2 (previously 2019-nCoV) diagnostics as well as implementation barriers was conducted. The data provided by 47 laboratories in 30 EU/EEA countries were taken into account in a study released by Eurosurveillance.
The laboratories were asked to indicate their weekly capacity for molecular testing for SARS-CoV-2. Of the 47 participating laboratories, 38 indicated a capacity of minimum 8 275 tests per week.
At the time of the survey, an additional eight laboratories were in the process of implementing molecular diagnostics and these laboratories would, all combined, add a minimum capacity of 875 tests per week once this process would be complete.
Furthermore, the survey indicated a great willingness of laboratories to provide international diagnostic support and to share sequences to contribute to the monitoring of virus evolution and trace transmission chains.
The main challenges for test implementation were an initial lack of positive control, lack of personnel/time and a lack of primers and/or probes.
Read the full assessment
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
Latest updates
Further reading
Surveillance and monitoring
Communicable disease threats report, 29 June−5 July 2024, week 27
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 June−5 July 2024 and includes updates on SARS-CoV-2 variant classification, swine influenza, an overview of respiratory virus epidemiology in the EU/EEA, parvovirus infection, avian influenza, West Nile virus infections, mass gatherings and botulism.
Surveillance and monitoring
Communicable disease threats report, 22-28 June 2024, week 26
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 June 2024 and includes updates on cholera, chikungunya and dengue, influenza, West Nile virus, and mass gathering monitoring or the UEFA European Football Championship and Hajj.
Surveillance and monitoring
Communicable disease threats report, 8-14 June 2024, week 24
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 June 2024 and includes updates on avian influenza, an overview of respiratory virus epidemiology in the EU/EEA, cholera, West Nile virus infections, measles and mass gatherings.
Surveillance and monitoring
Communicable disease threats report, 1-7 June 2024, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
Surveillance and monitoring
Communicable disease threats report, 25-31 May 2024, week 22
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25-31 May 2024 and includes updates on avian influenza, respiratory viruses, invasive meningococcal disease, mass gatherings for Hajj in Saudi Arabia, cholera, chikungunya, dengue, and poliomyelitis.